Delivery Order SPE2DB22D2206-SPE2DB25FGN54

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract is a delivery order with a firm fixed price of $1,257.48 and a period of performance through April 2, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,399.00 delivery order contract is for the provision of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price pricing type and a completion date of July 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $40,239.36, is a firm fixed price delivery order, and has an ultimate completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price of $13,213.96 and a completion date of February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RABAVERT rabies vaccine with diluents, with a ceiling value of $2,303.10 and a completion date of January 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the procurement of RABAVERT rabies vaccine with diluents, with a ceiling value of $1,257.48. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 10, 2025. The contract is not designated as a set-aside, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $10,479.00. The contract is a firm-fixed-price delivery order, with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of RABAVERT rabies vaccine with diluents, with a ceiling value of $4,191.60 and a period of performance through January 16, 2025. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $54,048.40, has a firm fixed price and an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award, valued at $54,918.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product used for rabies prevention and treatment. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGN54
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of RABAVERT rabies vaccine with diluents, with a ceiling value of $47,140.18 and a period of performance through April 15, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:50 AM